Marathon Petroleum (MPC)
(Delayed Data from NYSE)
$157.90 USD
+0.88 (0.56%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $158.00 +0.10 (0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$157.90 USD
+0.88 (0.56%)
Updated Oct 16, 2024 04:00 PM ET
After-Market: $158.00 +0.10 (0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value D Growth F Momentum C VGM
Zacks News
Should Pacer US Cash Cows 100 ETF (COWZ) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for COWZ
Is First Trust Large Cap Value AlphaDEX ETF (FTA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FTA
Should First Trust Large Cap Core AlphaDEX ETF (FEX) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FEX
Is Pacer US Cash Cows 100 ETF (COWZ) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for COWZ
Why Marathon Petroleum (MPC) Dipped More Than Broader Market Today
by Zacks Equity Research
Marathon Petroleum (MPC) closed the most recent trading day at $148.38, moving -1.66% from the previous trading session.
CRISPR Therapeutics and Dollar General have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
CRISPR Therapeutics and Dollar General are part of the Zacks Bull and Bear of the Day article.
3 Dividend Stocks to Watch in a Volatile Energy Market
by Nilanjan Banerjee
Three energy stocks, Marathon (MPC), EOG Resources (EOG) and Phillips 66 (PSX), are well-poised to gain, though the oil pricing scenario, since the onset of the pandemic, looks extremely volatile.
Marathon Petroleum (MPC) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Marathon Petroleum (MPC) closed the most recent trading day at $141.58, moving -1.12% from the previous trading session.
Is First Trust Large Cap Core AlphaDEX ETF (FEX) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FEX
Marathon Petroleum (MPC) Down 5% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Marathon Petroleum (MPC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should First Trust Large Cap Value AlphaDEX ETF (FTA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FTA
Should You Invest in the First Trust NASDAQ Oil & Gas ETF (FTXN)?
by Zacks Equity Research
Sector ETF report for FTXN
Are Oils-Energy Stocks Lagging Marathon Petroleum (MPC) This Year?
by Zacks Equity Research
Here is how Marathon Petroleum (MPC) and Oceaneering International (OII) have performed compared to their sector so far this year.
Should Invesco S&P 500 GARP ETF (SPGP) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPGP
Is First Trust NASDAQ Oil & Gas ETF (FTXN) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FTXN
Marathon (MRO) Q3 Earnings Top as U.S. Output Grows, Cost Falls
by Zacks Equity Research
Marathon Oil (MRO) spent $4499 million in capital and exploratory expenditures during the quarter and raked in $718 million in adjusted free cash flow.
Murphy (MUSA) Q3 Earnings Beat Despite Lower Gasoline Prices
by Zacks Equity Research
the third quarter, Murphy USA (MUSA) bought back shares worth $65.3 million.
Marathon (MPC) Q3 Earnings Top Despite a Decline in Margins
by Zacks Equity Research
In the third quarter, Marathon Petroleum (MPC) repurchased $2.8 billion of shares and a further $1 billion worth of shares in October.
Marathon Petroleum Corporation (MPC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Marathon Petroleum (MPC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Marathon Petroleum (MPC) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Marathon Petroleum (MPC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marathon Petroleum (MPC) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Marathon Petroleum (MPC) delivered earnings and revenue surprises of 4.49% and 17.95%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the iShares U.S. Oil & Gas Exploration & Production ETF (IEO)?
by Zacks Equity Research
Sector ETF report for IEO
5 Stocks to Watch on Recent Dividend Hikes Amid Volatility
by Zacks Equity Research
Investors may keep a tab on stocks like WST, SXI, WCN, MPC and EQIX, which have lately hiked their dividend payments.
Are Oils-Energy Stocks Lagging Marathon Petroleum (MPC) This Year?
by Zacks Equity Research
Here is how Marathon Petroleum (MPC) and Iris Energy Limited (IREN) have performed compared to their sector so far this year.
Can Marathon (MPC) Retain Its Beat Streak in Q3 Earnings?
by Zacks Equity Research
Marathon (MPC) is likely to see gains in refining margins, despite a throughput drop in the third quarter. MPC's cost reduction might have boosted its bottom line.